Metabolic-Fit / 100
GOAL.MD review
A named, NPI-verifiable physician (Dr. Michael Mimlitz, MD) backs a standard $199/mo semaglutide and $299/mo tirzepatide rate — the ad copy leads with a $50-off first-month promo, but the page itself discloses the real ongoing number. It also runs a separate brand-name-access pathway, though that one publishes no price.
then $199/mo ongoing
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
GOAL.MD at a glance
- Semaglutide
- $199/mo
- Tirzepatide
- $299/mo
- Coverage
- Nationwide, per its own site
- Brand-name
- Yes
How we scored GOAL.MD
Every factor comes from GOAL.MD's own published pricing, disclosures and oversight, and the six combine into the 47/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- goal.md/weight-loss/semaglutide-injection
$199 for semaglutide and $299 for tirzepatide are the standard monthly rates; the $149 and $249 in the marketing are $50 off your first month only. GOAL.MD names its prescribing physician with a searchable NPI, which is more accountability than most of this list offers.
What to expect when you sign up
We walked GOAL.MD's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Each product page states the promo and standard price directly: "$X your first month, then $Y/mo"
- 2Free consultation with a licensed U.S. physician
- 3Medications dispensed by licensed U.S. pharmacies
- 4Site states "No auto-billing" for the ongoing charge
What we noticed
- Medically reviewed by a named, NPI-verifiable physician: Dr. Michael Mimlitz, MD (NPI 1508891870), Chief Physician of GOAL.MD
- A dedicated "Brand-Name GLP-1 Access" page exists for manufacturer-channel brand medication, though no price is published there
- The headline ad copy leads with the $149/$249 first-month promo rate, not the $199/$299 standard rate — read past the first line
- No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $149 → $199 | Standard monthly"$149 your first month ($50 off), then $199/mo" — the standard ongoing rate is $199, not the first-month promo. |
| Compounded tirzepatide | $249 → $299 | Standard monthly"$249 your first month ($50 off), then $299/mo" — same promo-then-standard structure. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what GOAL.MD's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Names an NPI-verifiable physician (Dr. Michael Mimlitz, MD) rather than an anonymous clinical network
- The standard ongoing rate ($199/$299) is disclosed on the same page as the promo, not hidden
- Nationwide, with a separate brand-name-access pathway for FDA-approved medication
- States "No auto-billing" for the ongoing charge
The caveats
- Marketing leads with the $50-off promo rate, not the standard monthly price — read the fine print
- No price published for the brand-name-access pathway
- No mention anywhere of pregnancy, breastfeeding, postpartum recovery, or PCOS
GOAL.MD for mothers: our verdict
A named, NPI-verifiable physician (Dr. Michael Mimlitz, MD) backs a standard $199/mo semaglutide and $299/mo tirzepatide rate — the ad copy leads with a $50-off first-month promo, but the page itself discloses the real ongoing number. It also runs a separate brand-name-access pathway, though that one publishes no price. The advertised entry is $149, but the standing rate settles near $199/month — so read the headline as a starting offer, not the monthly cost.
We weigh GOAL.MD the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What GOAL.MD costs, in full
- Compounded semaglutide — Standard monthly: $149 to start, then $199/mo
- Compounded tirzepatide — Standard monthly: $249 to start, then $299/mo
That lands within a few dollars of the ~$179/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
GOAL.MD says the price covers the provider visit and the medication. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications GOAL.MD prescribes
GOAL.MD prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. Brand pens are available here alongside the compounded versions, and the on-label products come with the manufacturer's own pregnancy and lactation labeling — easier to hand to an OB.
Where GOAL.MD fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Everything GOAL.MD states publicly checked out at last review: pricing, pharmacies and clinical network were all verifiable. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
GOAL.MD is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who want a named, checkable physician behind the prescription and are comfortable reading past a first-month promo to the real standard rate.
Alternatives to GOAL.MD
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing GOAL.MD
Head-to-head & alternatives
GOAL.MD, answered
- Is GOAL.MD's $149/mo price the real ongoing rate?
- No — that's the first-month promo ($50 off). The page itself says "then $199/mo" for semaglutide and "then $299/mo" for tirzepatide going forward.
- Does GOAL.MD offer brand-name Wegovy or Zepbound?
- It has a dedicated "Brand-Name GLP-1 Access" page for manufacturer-channel medication, but no price is published there as of our review — ask directly before assuming a number.
Pricing, states and verification reflect GOAL.MD's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.